helps to optimise the value of innovation

When to inflate or discounting costs?  Have a look at our last blog.

Data collection

How to collect robust clinical evidence & epidemiology data needed for your P&R dossier in Belgium, Luxembourg or The Netherlands?

Delphi panels or survey?
Targeted or systematic?
How to validate?

 
 

We know the frustration: you receive a lot of data from head office, data that is not particularly relevant, or very limited data.

Patient flow

And what about clinical practice? We are often asked to estimate how many patients there are exactly, and what these patients go through in clinical practice. What is the therapeutic schedule followed, and how does your innovation affect this, taking your future marketing authorisation and reimbursement criteria into account.

Survey and Delphi panel techniques

HEBIAS provides the required framework and transparently discusses a plan of action. Achievable and efficient. We help you draft a to-the-point questionnaire you can send to your key opinion leaders or other stakeholders, and provide a clear overview of the results as required.

We will also organise independent Advisory Boards and Delphi panels for you, and moderate as desired. You will receive a report with clear, consolidated data that can be used immediately in your further analyses.

Literature search

We also search the literature – deterministically or systematically – to advance your project in a bespoke way, and can sometimes achieve a great deal with limited information.

Database

As a client, you will be given the opportunity to access the information in our unique database. HEBIAS has historical Belgian data since 2010 on 8.000 medicinal products and knows exactly when they were launched, when price changes occurred, or what indications these were related to.

However, you are right, this is a complex matter. Don’t worry, we will gladly help you on your way and. In addition, we have our extensive network to consult for highly specialised matters.

MARKET ACCESS =

Clinical trials P & R activities Launch Post-patent activities